Development of a locally advanced orthotopic prostate tumor model in rats for assessment of combined modality therapy

Vasu Tumati, Sanjeev Mathur, Kwang Song, Jer Tsong Hsieh, Dawen Zhao, Masaya Takahashi, Timothy Dobin, Leah Gandee, Timothy D. Solberg, Amyn A. Habib, Debabrata Saha

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


The purpose of this study was to develop an aggressive locally advanced orthotopic prostate cancer model for assessing high-dose image-guided radiation therapy combined with biological agents. For this study, we used a modified human prostate cancer (PCa) cell line, PC3, in which we knocked down a tumor suppressor protein, DAB2IP (PC3 KD). These prostate cancer cells were implanted into the prostate of nude or Copenhagen rats using either open surgical implantation or a minimally invasive procedure under ultrasound guidance. We report that: i) these DAB2IP-deficient PCa cells form a single focus of locally advanced aggressive tumors in both nude and Copenhagen rats; ii) the resulting tumors are highly aggressive and are poorly controlled after treatment with radiation alone; iii) ultrasound-guided tumor cell implantation can be used successfully for tumor development in the rat prostate; iv) precise measurement of the tumor volume and the treatment planning for radiation therapy can be obtained from ultrasound and MRI, respectively; and v) the use of a fiducial marker for enhanced radiotherapy localization in the rat orthotopic tumor. This model recapitulates radiation-resistant prostate cancers which can be used to demonstrate and quantify therapeutic response to combined modality treatments.

Original languageEnglish (US)
Pages (from-to)1613-1619
Number of pages7
JournalInternational journal of oncology
Issue number5
StatePublished - May 2013


  • Animal MRI
  • Prostate cancer
  • Radioresistance
  • Ultra-sound and image-guided radiation therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Development of a locally advanced orthotopic prostate tumor model in rats for assessment of combined modality therapy'. Together they form a unique fingerprint.

Cite this